MedPath

The impact of micronutrients and docosahexaenoic acid (DHA) on cognitive development of school-aged children: the NEMO studies

Completed
Conditions
Cognitive development
Nervous System Diseases
Registration Number
ISRCTN75362637
Lead Sponsor
nilever Nederlands BV (The Netherlands)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
780
Inclusion Criteria

1. Children aged 6-9 years of age from six selected schools in urban Jakarta and 42 public schools in Southern Australia
2. Parents or carers provided informed consent

Exclusion Criteria

In the two study sites:
1. Children with severe physical and neurological health problems
2. No (intended) use of micronutrient/mineral and/or fatty acid supplements

In addition in Indonesia:
3. Children who are severely malnourished (weight/height Z-score less than or equal to -3 standard deviation [SD]) or severely anaemic (haemoglobin less than 8 g/l)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath